Park Ha Biological Technology is trading at $2.95, up 7.27%, with no clear catalyst identified.
- No new company-specific announcement dated August 31, 2026 was identified; CNBC reports no recent news for the security.
- Recent coverage concerns an ongoing shareholder lawsuit, not a positive catalyst.
- Broader U.S. markets are lower, while trading activity and volume were unavailable.